Oxford Immunotec Limited Release: New Study Confirms 98.9% Specificity of Oxford Immunotec’s T-SPOT(R)TB Assay

OXFORD, England & MARLBOROUGH, Mass.--(BUSINESS WIRE)--The authors of a recent peer-reviewed study published in the International Journal of Tuberculosis and Lung Disease confirmed the high specificity of the T-SPOT.TB assay.